Company overview
AeroSafe Global provides cold chain solutions tailored for the biopharmaceutical, specialty pharmacy, and medical device industries, ensuring that temperature-sensitive products are delivered safely and sustainably. The company’s services encompass the design, implementation, and distribution of thermal-controlled solutions, utilizing high-performance insulation to create smaller and lighter proprietary packaging. This approach not only maintains the integrity of pharmaceutical products during transit but also contributes to environmental sustainability. Additionally, AeroSafe’s advanced data analytics and real-time monitoring capabilities help clients proactively manage risks and optimize supply chain efficiency. AeroSafe owns the entire supply chain—from packaging and thermal monitoring to delivery, product efficacy, and environmental sustainability.
The company offers a reusable thermal container program known as AeroLoop. This program—part of its “cold-chain-as-a-service” (CCaaS) model—operates on a pay-per-turn basis, allowing clients to pay only for the containers they use, eliminating upfront costs and long-term commitments. This flexible model is designed to accommodate the varying needs of AeroSafe’s clients. Each CCaaS contract includes AeroSafe’s thermal packaging, outsourced supply chain management, and a temperature monitoring control tower, ensuring seamless delivery from manufacturer to end-user. By shifting from single-use packaging to a managed reuse program, AeroSafe helps biopharma companies lower operational costs while significantly reducing waste and carbon emissions.
Customers and target markets
- Merck
- Gilead Sciences
- Pfizer
- Amgen
- Baxter
Company metrics
- Headquarters:
- Rochester, New York
- Company size:
- 51-200
- Founded:
- 1995
- Industries:
